FDA Deems GM Apples, Potatoes Safe

Genetically modified, non-browning apples and bruise-resistant potatoes are safe, the US Food and Drug Administration says.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

An Arctic Granny apple (right) resists browning after eight hours exposed to air, as compared with an unmodified variety (left).OKANAGAN SPECIALTY FRUITSThe US Food and Drug Administration (FDA) has deemed genetically modified (GM), non-browning “Arctic” apples—approved last month by the Department of Agriculture—and bruise-resistant “Innate” potatoes “as safe and nutritious as their conventional counterparts,” according to The New York Times.

Okanagan Specialty Fruits, the British Columbia-based firm that produces the GM apples, and J.R. Simplot of Idaho, which grows the GM potatoes, both consulted with the FDA to assess the safety and nutrition of their foods.

“The consultation process includes a review of information provided by a company about the nature of the molecular changes and the nutritional composition of the food compared to traditionally bred varieties,” Dennis Keefe, director of the agency’s Office of Food Additive Safety, said in a statement. “This case-by-case safety evaluation ensures that food safety issues are resolved prior to commercial distribution.”

The agency also urged both companies to consult with the FDA about potential labeling requirements. Simplot told the Associated Press (AP) that it plans to deliver Innate potato ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Tracy Vence

    This person does not yet have a bio.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio 
Zymo Research

Zymo Research Launches Microbiome Grant to Support Innovation in Microbial Sciences